A regulatory region involved in both autoinhibition and calmodulin (CaM) binding has previously been identified in the multifunctional Ca2l/CaM-dependent protein kinase (CaM kinase H). We have tested the role of various segments of the regulatory region in autoinhibition by the analysis of a series of truncation, substitution, and deletion mutants of the CaM kinase H a subunit (CaM kinase Ha). Unexpectedly, the sequence Lys-Lys-Phe-Asn at positions 291-294, adjacent to the CaM binding domain, was found to be sufficient to maintain an inhibited state in a truncated form of the kinase. However, these residues are not essential in the context of the full-length protein, indicating the importance of additional residues from the overlapping CaM binding domain. We propose here a molecular model for CaM kinase Hea based on the three-dimensional structure of the cAPK-PKI-(5-24) (protein kinase inhibitor fragment) complex. It is predicted from this model that autoinhibition is of the pseudosubstrate variety and that autophosphorylation of Thr-286 could occur by an intersubunit reaction in the holoenzyme complex.
Ca2+/calmodulin (CaM)-dependent protein kinase (CaM kinase II) is one of several serine/threonine protein kinases known to be maintained in an inactive state by the interaction of the catalytic region with an autoinhibitory domain located on the same polypeptide (1) (2) (3) (4) . These enzymes can be activated by limited proteolysis, which removes the autoinhibitory domain. In the cAMP-dependent protein kinase (cAPK) (5) , the inactive state of the holoenzyme is maintained by an inhibitory amino acid sequence located on the regulatory subunit. Upon dissociation of the regulatory subunit, the enzyme can also be inhibited by interaction with the thermostable protein kinase inhibitor (PKI) . Synthetic peptides derived from PKI have provided evidence that inhibition occurs by the interaction of a pseudosubstrate sequence on the PKI with the active site. This pseudosubstrate type of inhibition is also the mechanism involved in the intrasteric regulation ofMLCK and PKC and has now been proposed for CaM kinase 11 (1) (2) (3) (4) 6) .
CaM kinase II, the most abundant protein kinase in brain tissue (7) , is a multimer of 10-12 catalytic subunits. All subunit types described to date (a, 1A, 13', y, 8) have an NH2-terminal catalytic domain containing the conserved blocks of homology found in serine/threonine kinases (8) , a central regulatory domain, and a COOH-terminal domain responsible for the association of the subunits into a multimer. Upon activation by Ca2+/CaM, CaM kinase II undergoes rapid autophosphorylation. In the a subunit, the predominant type in forebrain, this occurs by phosphorylation of Thr-286 (9) . This event is responsible for the development of an autonomous catalytic activity that is maintained even after removal of Ca2+/CaM from the enzyme.
Efforts have been made to map the regulatory region of CaM kinase II. Our studies showed that residues 291-294 were required for a synthetic peptide analog to inhibit the Ca2+/CaM-independent form ofthe kinase (10) . Other groups revealed that inhibitory potency could be enhanced by using longer peptides containing Thr-286 (11) (12) (13) . Site-directed mutagenesis studies have predominantly been restricted to attempts to mimic the effect of autophosphorylation by replacement of Thr-286 and its neighboring residues with negatively charged amino acids (14) (15) (16) . Since none of these mutations resulted in complete autonomous activity, other residues within the autoinhibitory domain must be involved in establishment of the autoinhibitory state.
For this study of residues of the regulatory region responsible for autoinhibition we generated a series of truncation, substitution, and deletion mutants of the a subunit of CaM kinase II and measured their Ca2+/CaM-independent activity. We show that residues 291-294 are sufficient to impart autoinhibition to a truncated form of the kinase and that, in the context of the full-length enzyme, amino acids involved in binding CaM also may participate in autoinhibition. In addition, a molecular model is proposed for the threedimensional structure of a truncated form of CaM kinase Ila based on similarities to the structure of the cAPK complexed to its inhibitor peptide.
METHODS
Site-Directed Mutagenesis and Expression of Mutants. A cDNA encoding rat brain CaM kinase Ila (17) was introduced into either pET3a (18) or p17-7 (19) after generation of a Nde I site at the translation initiation codon by site-directed mutagenesis (20) . All mutants were made by the same method. The sequence of oligonucleotides used for generation of truncation ("stop"), deletion (del.), and substitution (subst.) mutants are available upon request. The resulting constructs, pETCKa and pT7-CaMk, allowed the expression of proteins in Escherichia coli by induction of 17 RNA polymerase or by in vitro transcription/translation. Purified DNA from clone pETCKa and each one of the mutants was transcribed as described (22 (22) . Expression of translated mutant proteins relative to wild type (wt) was compared by the intensity of radiolabeled products on SDS/PAGE. For measurement of kinase activity, identi-cal reactions were carried out with unlabeled methionine. RNA was omitted from control reactions.
CaM Overlays, Inunobots, and Kinse Assays. To visualize expressed proteins, 5 1d of labeled translation reactions were loaded on 10o polyacrylamide gels, autoradiographed, and quantified by laser scanning. For Western blots, E. coli cells carrying T7 polymetase-driven expression constructs (Fig. 1 ) of each mutant were induced to express CaM kinase Ila by infection with A phage carrying T7 polymerase. Western immunoblots (22) using a polyclonal antibody specific for the a subunit and 125I-labeled CaM overlays of crude bacterial lysates were carried out as described (23) . Kinase activity was measured as described (22, 24) by phosphorylation of a synthetic peptide derived from glycogen synthase (Pro-Leu-Arg-Arg-Thr-Leu-Val-Ala-Ala) (25) (Fig. 1) , and each one of the mutants was tested for its ability to bind Ca2+/CaM as well as both Ca2+/CaMdependent and Ca2+/CaM-independent kinase activity. For expression of mutated proteins, we used expression vectors driven by T7 polymerase which allowed production of the wild-type (wt) and mutant proteins either in E. coli or by in vitro transcription/translation. However, since bacterial expression of CaM kinase Ila invariably yields also a fragment of about 33 kDa (11, 28) , we preferred the in vitro translation system as a source of enzyme for our kinase assays and used bacterial expressed proteins only in CaM-overlay assays.
As predicted from previous studies of synthetic peptides suggesting that residues 296-309 are important for Ca2+/ CaM binding (6), truncation mutants ending at positions 306, 298, 294, and 290 did not bind Ca2+/CaM, while loger versions of the enzyme terminating at 317 and 326 or the full-length polypeptide bound Ca2+/CaM (Fig. 2B) . No highaffinity binding was detected in the mutant ending at residue 310, suggesting that Arg-311 corresponds to an arginine shown to be essential for CaM binding in other enzymes (23 (27) . COOH-terminal truncations were made that maintained the catalytic region intact. Substitutions were made in the context of the full-length kinase with new residues underlined. The amino acids used for substitutions were chosen to avoid the introduction of charged or bulky side chains. In some cases, glycine residues were used to impart flexibility to the structure. Deletions are shown as angled lines. Autophos., autophosphorylation (site indicated by asterisk). Results obtained with the truncation mutants indicate that the COOH-terminal boundary of a minimal autoinhibitory domain lies between residues 291 and 294, NH2-terminal to the CaM-binding sequence, but COOH-terminal to Thr-286, the autophosphorylation site that confers Ca2+/CaMindependence (9) . These data (Fig. 2) concur with the observations that constitutively active fragments can be generated by truncation of the enzyme at residue 282 by site-directed mutagenesis (28) whereas proteolytic digestion can yield an inactive fragment ending at 293 (29) , suggesting that, while residues 283-290 are not sufficient to inhibit CaM kinase Iha, the addition of residues 291-293 (or 294) inhibits kinase activity. Alternatively, the lack of activity observed in the mutant truncated at 294 could be explained by improper folding caused by the addition of residues 291-294 to the mutant truncated at 290. However, this is unlikely since the longer truncated versions (Fig. 2) have activities near wt levels. It is noteworthy that a similar constitutively active truncation mutant has been constructed by using the mouse CaM kinase Ila (30) containing the additional sequence Lys-Arg-Pro-Ala-Gly-Met-Gln-Ala at the COOH terminus after Leu-290. The constitutive activity of this mutant suggests that the inhibition by residues 291-294 described here is specific. Finally, the activity of the mutant ending at 290 could not be attributed to phosphorylation of Thr-286 in this protein since mutation of Thr-286 to alanine did not alter the constitutive activity of the enzyme truncated at Leu-290 (not shown).
Having shown that extension of the constitutively active kinase by amino acids 291-294 was sufficient to inhibit catalytic activity, it was of interest to test the requirement for these residues when they were adjacent to the normal CaM binding domain. Therefore, we substituted Ala-Ala-Ala-Leu for the sequence Lys-Arg-Arg-Asn at positions 291-294 in the context of the full-length protein (Fig. 1C) . Like the enzyme isolated from mammalian brain, the full-length a subunit expressed in E. coli formed a multimer, as assessed by gel filtration (not shown). Multimer formation has been shown in other in vitro systems in which the a subunit has been expressed such as CHO cells (31) and baculovirus (32) . The mutant carrying the substitution at 291-294 was predominantly Ca2+/CaM-dependent with a low level (7%) of independent activity (Table 1) . However, disruption of the domain by deletion of these residues resulted in higher constitutive activity (38%). In addition, because of the higher inhibitory potency of synthetic peptides that include residues 283-289 (13, 33) , these amino acids were also substituted or deleted. As with the replacement of residues 291-294, mutation of 283-289 resulted in only a slight increase in independent activity, whereas deletion had a larger effect. More drastic changes in enzymatic properties were introduced by replacement or deletion of the entire sequence 283-294. In both cases the resulting mutants showed 95% independent activity, suggesting a nearly complete disruption of intrasteric regulation.
That the truncation mutant ending at Leu-290 was unregulated with a total activity similar to that of activated fulllength enzyme, while residues 291-294 are sufficient to confer autoinhibition of the truncated kinase but were not essential in the context of the full-length enzyme, suggests that an extended domain beyond Leu-290 could be involved in autoinhibition. The ability of sequences other than residues 291-294 to provide autoinhibition would be consistent with the observation that deletions result in larger increases in independent activity, whereas short substitutions with noncharged residues have milder effects. Thus, residues NH2-terminal to position 291 would be unlikely to play a direct role in the intrasteric inhibition but would ensure the correct positioning of the autoinhibitory domain. The extended autoinhibitory domain would then encompass Phe-293, followed by separate blocks of basic and hydrophobic residues. This pattern of side chains is reminiscent ofthat ofthe peptide inhibitor of cAPK, PKI-(5-24) (Fig. 3) . In this peptide, phenylalanine at position 11 [P(-11)] upstream from phosphorylation site P(0) [Phe-(-11); corresponds to Phe-293 of CaM kinase ITa] is critical for high-affinity binding to the catalytic subunit, and substitution of this amino acid decreases affinity by a factor of 100 (34) . The importance of Phe-293 and the similar pattern of side chains suggested that the intrasteric autoinhibition of CaM kinase II could have functional and structural similarities to the inhibition of cAPK by the inhibitor peptide. Thus, we prepared a model for CaM kinase Iha based on the three-dimensional structure of the catalytic subunit of cAPK and modeled the autoinhibitory domain according to the coordinates of PKI-(5-24) (35, 36) . A similar approach has been used recently to elaborate a model for smooth muscle MLCK (37) . Fig. 4 compares the structures of the cAPK-PKI-(5-24) complex with our model for CaM kinase Iha. In Fig. 4A , the NH2-terminal end of cAPK (in magenta) contains a long a-helix (helix A) absent in CaM kinase Iha. Residues 31-296 of cAPK (shown in cyan) represent the core of the enzyme homologous to the catalytic region of CaM kinase Iha (residues 1-270). The last residue conserved in this region is Trp-296 (Trp-270 in CaM kinase Iha) and is shown in yellow. The sequence following Trp-296 is a random coil structure (magenta) with no homology to CaM kinase Iha. The catalytic core is composed of two lobes. The upper lobe, mainly formed by ,-strands, is involved in binding ATP (Lys-72 of the phosphate anchor is displayed in blue). The lower lobe, rich in a-helices, is responsible for interacting with the peptide. Within this lobe, residues Glu- 127 and -170 are involved in recognizing the basic residues found in the consensus cAPK substrates [positions P(-3) and P(-2), respectively]. The inhibitor peptide (in green) is composed of an NH2-terminal five-residue a-helix containing Phe-(-11) (displayed in orange), followed by an extended structure containing the pseudosubstrate sequence. Phe-(-11) interacts with a hydrophobic pocket between helices F and G of the kinase, formed by Tyr-210 and Phe-214.
To build our model, we aligned the catalytic subunit (residues 1-350) with residues 1-317 of CaM kinase Ila. This alignment showed that residues 1-270 of CaM kinase Iha contained all of the blocks of homology typical of serine/ threonine protein kinases. Furthermore, all a-helices and a-strands would be predicted to have the same length as in cAPK, except for helix ,B (on the small lobe), which is one residue shorter. Other inserts or deletions in the CaM kinase Ila would be predicted to occur in loops. Several residues within a-helices and f3-strands as well as within loops involved in binding the peptide inhibitor are remarkably conserved. In particular, (i) Glu-% is situated at a position equivalent to Glu-127 in cAPK and could be involved in recognizing the basic residue required at position P(-3) in most CaM kinase II substrates; (ii) the hydrophobic loop involved in interacting with a nonpolar residue at the P(+1) position in both cAPK and CaM kinase Iha is conserved; (iii) unlike cAPK, CaM kinase Ila does not require a second basic residue at position P(-2), as the latter enzyme does not contain a residue equivalent of Glu-230; and finally (iv) conservation of the hydrophobic pocket between helices F and G (Gly-Tyr-Pro-Pro-Phe-Phe-Ala-Asp at 234-241 in cAPK, and Gly-Tyr-Pro-Pro-Phe-Trp-Asp-Glu at 209-216 in CaM kinase Ila), which is the site of the high-affinity interaction with Phe-(-11) on the inhibitor.
When optimally aligned, amino acids of CaM kinase Ila are equivalent to residues 31-2% of cAPK. In the model, each of the side chains of cAPK in this region was replaced with the side chains of the equivalent residue in CaM kinase Ila on the a-carbon backbone of the cAPK structure. After all the side chains had been replaced, the entire modeled structure was energy-minimized to ensure the best possible fit. This replacement did not affect the overall distribution of charged residues preferentially exposed to the solvent or hydrophobic residues predominantly directed inwards. Subsequently, the structure of residues from Asp-288 to Met-306 (regulatory region) was modeled according to the coordinates of PKI-(5-24) by aligning Phe-293 of CaM kinase Iha and Phe-(-11) of PKI-(5-24) as shown in Fig. 3 (32) and could explain the tight inhibition of the kinase in the absence of Ca2+/CaM. (ii) Some of the residues involved in CaM binding (Arg-Lys-Leu-Lys-Gly-Ala-IeLeu-Thr-Thr-Met-Leu-Ala-Thr-Arg at 296-311) at the COOH-terminal end of the regulatory region could also be involved in a direct interaction with the catalytic site (either the ATP binding loop or the residues involved in recognizing the substrate). The a-helical character of PKI-(5-24) is limited to the first eight residues, whereas the COOHterminal 12 residues adopt a relaxed conformation that in CaM kinase II could be more extended, allowing the positioning of Lys-298 at position P(-6), Lys-300 at P(-3), Ile-303 at P(0), and Leu-304 at P(+ 1 (1992) has been provided by anisotropy measurements of a monomeric recombinant CaM kinase (38) . These 
